Home > Press > Platypus Technologies Receives Phase I SBIR for $200k
Platypus Technologies Receives Phase I SBIR for $200k
July 27, 2005
Platypus Technologies has received a Phase I Small Business Innovation Research (SBIR) grant for $200,000 from the National Cancer Institute. The grant is to develop a new liquid-crystal based technology for rapid quantification of protein activity, useful for cancer research.
Platypus Technologies was founded in 2000 to develop nanotechnology products for the physical and life sciences.
About Platypus Technologies:
Platypus Technologies, LLC develops, produces and markets nanotechnologies for the life sciences. We produce a variety of nano-structured surfaces for use in research and are also developing a range of products that derive from a proprietary platform technology using liquid crystals for the rapid detection of molecular interactions. This technology fuses recent advances in nano-scale science, materials science and molecular biology to provide advanced tools for proteomics, cell studies, environmental monitoring and in vitro diagnostics.
Currently, Platypus offers obliquely-deposited gold slides, gold-coated glass slides / mica / silicon wafers / coverslips, optically transparent polyurethane substrates with topography, Functionalization Kits and Contact Printing Kits.
For more information, please visit www.platypustech.com
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over 14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||